左心室辅助装置卸载后终末期心力衰竭心肌纤维化持续存在的细胞特异性通路
尽管血流动力学卸载有效,毛细血管密度、心肌纤维化和巨噬细胞密度均无显著变化,但成纤维细胞特异性胶原表达下降16.7倍,巨噬细胞促纤维化信号转变。提示持续炎症和细胞外基质重塑不良可能阻碍心肌恢复。
要点
- LVAD卸载后心肌纤维化和毛细血管密度无显著改变。
- 成纤维细胞特异性胶原表达下降16.7倍,但纤维化面积不变。
- 巨噬细胞促纤维化信号转变,持续炎症可能阻碍恢复。
核心结论
- 尽管LVAD有效卸载,毛细血管密度和纤维化与负载心脏相比无变化。
- 成纤维细胞特异性胶原表达下降,可能与拉伸减少或巨噬细胞极化改变有关。
- 功能失调心肌可能部分因持续炎症和细胞外基质重塑不良而持续存在。
研究设计与样本
- 研究获取接受LVAD植入和/或心脏移植受试者的心肌组织。
- 进行详细组织学分析,并在可行时从新鲜解离心肌中分离单核细胞进行定量逆转录聚合酶链反应研究。
主要发现
- LVAD使用后毛细血管密度无差异(0.78±0.1% vs. 0.9±0.1%毛细血管面积;n=42和28;p=0.40)。
- 心肌纤维化无差异(25.7±2.4% vs. 27.9±2.4%纤维化面积;n=44和31;p=0.50)。
- 巨噬细胞密度无差异(80.7±10.4巨噬细胞/mm2 vs. 108.6±15巨噬细胞/mm2;n=33和28;p=0.1)。
- 成纤维细胞特异性胶原表达下降16.7倍(p<0.01),尽管纤维化和肌成纤维细胞密度无变化(p=0.40)。
- LVAD使用后巨噬细胞信号从促纤维化/替代性促纤维化转变。
临床怎么用
- LVAD卸载后心肌纤维化未逆转,提示需针对持续炎症和基质重塑的辅助治疗。
- 成纤维细胞胶原表达下降但纤维化面积不变,监测纤维化需结合组织学而非仅分子指标。
局限性
- 仅描述性组织学和基因表达分析,未明确因果机制。
- 单核细胞分离仅在可行时进行,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Only limited data exist describing the histologic and noncardiomyocyte function of human myocardium in end-stage heart failure (HF). OBJECTIVES: The authors sought to determine changes in noncardiomyocyte cellular activity in patients with end-stage HF after left ventricular assist device (LVAD)-induced remodeling to identify mechanisms impeding recovery. METHODS: Myocardium was obtained from subjects undergoing LVAD placement and/or heart transplantation. Detailed histological analyses were performed, and, when feasible, mononuclear cells were isolated from fresh, dissociated myocardium for quantitative reverse transcription polymerase chain reaction studies. Echocardiographic and catheterization data were obtained during routine care. RESULTS: Sixty-six subjects were enrolled; 54 underwent 8.0 ± 1.2 months of LVAD unloading. Despite effective hemodynamic unloading and remodeling, there were no differences after LVAD use in capillary density (0.78 ± 0.1% vs. 0.9 ± 0.1% capillary area; n = 42 and 28, respectively; p = 0.40), cardiac fibrosis (25.7 ± 2.4% vs. 27.9 ± 2.4% fibrosis area; n = 44 and 31, respectively; p = 0.50), or macrophage density (80.7 ± 10.4 macrophages/mm2 vs. 108.6 ± 15 macrophages/mm2; n = 33 and 28, respectively; p = 0.1). Despite no change in fibrosis or myofibroblast density (p = 0.40), there was a 16.7-fold decrease (p < 0.01) in fibroblast-specific collagen expression. Furthermore, there was a shift away from pro-fibrotic/alternative pro-fibrotic macrophage signaling after LVAD use. CONCLUSIONS: Despite robust cardiac unloading, capillary density and fibrosis are unchanged compared with loaded hearts. Fibroblast-specific collagen expression was decreased and might be due to decreased stretch and/or altered macrophage polarization. Dysfunctional myocardium may persist, in part, from ongoing inflammation and poor extracellular matrix remodeling. Understanding these changes could lead to improved therapies for HF.
引用
- Farris SD, Don C, Helterline D, et al. Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure. J Am Coll Cardiol. 2017. PMID: 28705316. doi:10.1016/j.jacc.2017.05.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。